A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

The aim of the reported trial was to investigate the safety and efficacy of memantine in mild to moderate vascular dementia (VaD). This was a 28-week, double-blind, parallel, randomized controlled trial of memantine 20 mg daily versus placebo which was conducted in 54 centres in the UK. Memantine is...

Descripció completa

Dades bibliogràfiques
Autors principals:	Wilcock, G, Möbius, H, Stöffler, A
Format:	Journal article
Idioma:	English
Publicat:	2002

Ítems similars

Memantine for the treatment of dementia.
per: Wilcock, G
Publicat: (2003)

Memantine for dementia.
per: Mcshane, R, et al.
Publicat: (2006)

Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
per: Hanney, M, et al.
Publicat: (2012)

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
per: Majed Al-Jeraisy, et al.
Publicat: (2021-04-01)

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
per: Kieburtz, K, et al.
Publicat: (2013)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
per: Christien Janneke van der Woude, et al.
Publicat: (2022-04-01)

EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
per: M. A. Ninci, et al.
Publicat: (2016-01-01)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
per: Jones, R, et al.
Publicat: (2009)

Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialResearch in context
per: Yangqing Zhan, et al.
Publicat: (2024-01-01)

Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial
per: Pankaj Bhardwaj, et al.
Publicat: (2023-11-01)

Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)
per: Pin Wang, et al.
Publicat: (2024-07-01)

Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
per: Emma D. Frost, et al.
Publicat: (2024-11-01)

Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial
per: Neil A. Hagen, et al.
Publicat: (2017-01-01)

MMM in the finance-growth nexus
per: Achmad Tohirin, et al.
Publicat: (2011-11-01)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
per: Schneider, L, et al.
Publicat: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
per: Schneider, L, et al.
Publicat: (2011)

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
per: Wilcock, G, et al.
Publicat: (2006)

Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study.
per: Tohen, M, et al.
Publicat: (2008)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
per: Howard, R, et al.
Publicat: (2012)

Vascular dementia.
per: Amar, K, et al.
Publicat: (1995)

Vascular dementia.
per: Amar, K, et al.
Publicat: (1996)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
per: Wilcock, G
Publicat: (2007)

The clinical use of memantine
per: Burns, A, et al.
Publicat: (2005)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
per: Pavord, I, et al.
Publicat: (2012)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
per: Maki Komiyama, et al.
Publicat: (2023-04-01)

Multicentre Double-Blind Placebo-Controlled Food Challenge Study in Children Sensitised to Cashew Nut.
per: Johanna P M van der Valk, et al.
Publicat: (2016-01-01)

Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial
per: Wilcock, G, et al.
Publicat: (2005)

Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India
per: Ravikirti, et al.
Publicat: (2021-07-01)

A randomized double-blind placebo-controlled trial of an inhibitor of plasminogen activator inhibitor-1 (TM5614) in mild to moderate COVID-19
per: Toyohiro Hirai, et al.
Publicat: (2024-01-01)

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD).
per: Ballard, C, et al.
Publicat: (2015)

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
per: Wilcock, G, et al.
Publicat: (2008)

Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
per: Morice, A, et al.
Publicat: (2017)

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
per: Wang, Y, et al.
Publicat: (2020)

Nitroglycerin for treatment of retained placenta: a randomized, placebo-controlled, multicentre double blind trial in the UK
per: Denison, F, et al.
Publicat: (2019)

Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
per: Fiona C Denison, et al.
Publicat: (2019-12-01)

Diagnostic criteria for vascular dementia
per: Amar, K, et al.
Publicat: (1996)

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
per: A. David Burden, et al.
Publicat: (2023-09-01)

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
per: Thwaites, GE, et al.
Publicat: (2017)

How effective is topical miconazole or amorolfine for mild to moderately severe onychomycosis in primary care: the Onycho Trial – a randomised double-blind placebo-controlled trial
per: Mattijs E Numans, et al.
Publicat: (2024-05-01)

Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial
per: Chun-li Lu, et al.
Publicat: (2024-05-01)